Intervention

lisinopril

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 19 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19

Recruiting0

Common conditions25

Lead sponsors shown15

Clinical trials

19 shown

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy SubjectsNCT02070510 · 2014-02-27

Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung CancerNCT01880528 · 2013-05-31

Non-invasive Haemodynamic Assessment in HypertensionNCT01996085 · 2013-01-01

A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With LisinoprilNCT01398267 · 2011-08-01

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid TumorsNCT01234922 · 2011-02-01

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving TrastuzumabNCT01009918 · 2010-03-01

VA NEPHRON-D: Diabetes iN Nephropathy StudyNCT00555217 · 2008-07-01

The Antihypertensives and Vascular, Endothelial and Cognitive Function TrialNCT00605072 · 2008-01-01

Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural DiseaseNCT00553969 · 2007-11-01

Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.NCT00430040 · 2007-02-01

The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) TrialNCT00347360 · 2006-07-01

Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pHNCT01518166 · 2006-05-01

Evaluation of Periop Biochemical Stress Factors in Craniotomy Neurosurgical Procedure With Respect to Preop HypertensionNCT02441842 · 2006-03-01

COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And MicroalbuminuriaNCT00123903 · 2005-07-01

The CLEVER Study - Coreg And Left Ventricular Mass RegressionNCT00108082 · 2005-01-01

VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With MicroalbuminuriaNCT00171067 · 2004-07-01

Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With DiabetesNCT00241124 · 2004-04-01

Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)NCT00000542 · 1993-08-01

Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic NephropathyNCT00311870 · 1993-03-01

Common conditions

Leading sponsors

GlaxoSmithKline 3 Novartis 2 Novo Nordisk A/S 2 Hoffmann-La Roche 1 Mayo Clinic 1 Military Institute od Medicine National Research Institute 1 Milton S. Hershey Medical Center 1 National Heart, Lung, and Blood Institute (NHLBI) 1 Steno Diabetes Center Copenhagen 1 University at Buffalo 1 University of Minnesota 1 University of South Florida 1 University of Southern California 1 US Department of Veterans Affairs 1 Wake Forest University Health Sciences 1

Trial status mix

COMPLETED15

TERMINATED4

Phase mix

PHASE36

PHASE25

PHASE14

PHASE44

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.